The mechanism of urinary concentration in nephrogenic diabetes insipidus
- PMID: 188007
The mechanism of urinary concentration in nephrogenic diabetes insipidus
Abstract
The authors have evaluated urinary adenosine 3',5'-monophosphate (cyclic AMP) excretion and renal function during Pitressin administration, hypertonic saline administration, and water deprivation in two siblings with vasopressin-resistant diabetes insipidus and in normal control subjects. After vasopressin administration normal subjects experienced a 2-fold rise in urinary cyclic AMP excretion from 3.2 +/- 0.7 to 5.6 +/- 1.3 nmol/min (P less than 0.001) whereas cyclic AMP excretion was unchanged in both patients (patient AC 4.4 +/- 0.9 to 4.3 +/- 2.1; patient TC 2.2 +/- 0.9 to 2.6 +/- 0.9 nmol/min) with nephrogenic diabetes insipidus (NDI). Urinary cyclic AMP excretion was measured during infusion of 2.5% saline, after vasopressim administration, and after water deprivation. Cyclic AMP excretion was not different from control values in the NDI patients during any of the experimental conditions. Furthermore, there was no difference in cyclic AMP excretion when periods of dilute urine excretion (patient AC 4.5 +/- 1.1; patient TC 2.1 +/- 0.8 nmol/min) were compared with periods when urine concentration was greater than that of plasma (AC 3.5 +/- 1.3; TC 1.8 +/- 0.9 nmol/min). Both subjects responded to parathyroid hormone infusion with a 2-fold increase in urinary cyclic AMP excretion. Excretion of concentrated urine was paralleled by a marked decrease in urine flow to less than 1 ml/min/m2. During periods of hypotonic urine excretion (Uosm/Posm less than 1.0) average glomerular filtration rate (GFR) in patient AC was 67.0 +/- 3.0 ml/minm2 whereas in patient TC it was 70.1 +/- 8.1 ml/min/m2. When each patient was excreting a hypertonic urine (Uosm/Posm greater than 1.0) after fluid deprivation their GFR had decreased significantly (P = 0.001) to 31.6 +/- 8.9 and 33.3 +/- 10.3 ml/min/m2, respectively. Ability of these two subjects with NDI to concentrate their urine to Uosm/Posm greater than 1.0 in the absence of an increase in urinary cyclic AMP but associated with a decrease in GFR to 50% normal indicates that urinary concentration was effected by a reduction in GFR rather than a partial response to antidiuretic hormone (ADH). Their ability to concentrate their urine during periods of modest volume depletion would protect them from progressing to more severe stages of dehydration and result in the relatively benign course of their disease. It is feasible that in patients previously reported to have had clinically "partial" NDI this mechanism may have been operative.
Similar articles
-
Urine osmolality, cyclic AMP and aquaporin-2 in urine of patients under lithium treatment in response to water loading followed by vasopressin administration.Eur J Pharmacol. 2007 Jul 2;566(1-3):50-7. doi: 10.1016/j.ejphar.2007.03.038. Epub 2007 Mar 30. Eur J Pharmacol. 2007. PMID: 17466972 Clinical Trial.
-
[The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].Quad Sclavo Diagn. 1976 Mar;12(1):15-38. Quad Sclavo Diagn. 1976. PMID: 190633 Review. Italian.
-
Antidiuretic and urinary cyclic AMP response of vasopressin in normal rats and in rats with lithium-polyuria.Acta Pharmacol Toxicol (Copenh). 1977 Mar;40(3):447-54. Acta Pharmacol Toxicol (Copenh). 1977. PMID: 190861
-
Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.J Clin Invest. 1974 Sep;54(3):753-62. doi: 10.1172/JCI107813. J Clin Invest. 1974. PMID: 4368480 Free PMC article.
-
Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.Dan Med Bull. 1997 Apr;44(2):191-207. Dan Med Bull. 1997. PMID: 9151012 Review.
Cited by
-
Congenital nephrogenic diabetes insipidus.Arch Dis Child. 1979 Oct;54(10):807. doi: 10.1136/adc.54.10.807. Arch Dis Child. 1979. PMID: 507907 Free PMC article. No abstract available.
-
Sickle cell disease up-regulates vasopressin, aquaporin 2, urea transporter A1, Na-K-Cl cotransporter 2, and epithelial Na channels in the mouse kidney medulla despite compromising urinary concentration ability.Physiol Rep. 2019 Apr;7(8):e14066. doi: 10.14814/phy2.14066. Physiol Rep. 2019. PMID: 31033226 Free PMC article.